Last updated: September 26, 2021
Sponsor: Dongying Zhang
Overall Status: Completed
Phase
N/A
Condition
Heart Failure
Hyponatremia
Chest Pain
Treatment
N/AClinical Study ID
NCT05068934
2020-09
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Adult aged >=18years old;
- Diagnosed with HFpEF. Diagnostic criteria including:
- left ventricular ejection fraction ≥50%;
- with the symptoms and/or signs of heart failure;
- BNP≥35 pg/mL and/or NTproBNP≥125 pg/mL;
- at least one additional criterion: relevant structural heart disease(LVH and/or LAE)or diastolic dysfunction
Exclusion
Exclusion Criteria:
- LVEF less than 45% at any time;
- Severe liver failure;
- Primary pulmonary hypertension;
- Age <18 years old.
Study Design
Total Participants: 93
Study Start date:
October 12, 2020
Estimated Completion Date:
June 01, 2021
Study Description
Connect with a study center
The First Affiliated Hospital of Chongqing Medical University
Chongqing,
ChinaSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.